Test Price
1,500 AED✅ Home Collection Available
Babesia microti Antibodies (IgG & IgM) Test in Dubai | 1500 AED | DNA Labs UAE
Executive Summary & Core Metrics
Diagnostic Accuracy: 99.9% clinical sensitivity for combined IgG and IgM detection via CDC-standard Immunofluorescence Assay (IFA).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. ISO 9001:2015 certified specimen transport with real-time tracking.
Physician Guidance: Complimentary post-result telephonic consultation with a licensed general practitioner for result interpretation and clinical correlation.
Insurance Facilitation: Direct coverage verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Babesia microti IgG and IgM antibody panel employs Immunofluorescence Assay (IFA) technology aligned with CDC reference standards to provide definitive serological evidence of past or acute tick-borne babesiosis. This comprehensive panel differentiates early IgM response from long-lasting IgG antibodies, guiding clinical management in patients with relevant travel history, outdoor exposure in endemic regions, or immunocompromised status. Testing is performed at DNA Labs UAE within Dubai Healthcare City under strict ISO 9001:2015 quality management protocols.
| Feature | DNA Labs UAE – Premier IFA Serology | Alternative Molecular PCR Approach |
|---|---|---|
| Methodology | Immunofluorescence Assay (IFA) – CDC Reference Standard for antibody staging | Polymerase Chain Reaction (DNA detection, cannot distinguish past vs. active infection) |
| Diagnostic Sensitivity | 99.9% for combined IgG + IgM serological panel | Approximately 95% (may yield false negatives in low-parasitaemia presentations) |
| Turnaround Time | 14–21 days (batched reference testing; samples must arrive by the 7th of the month) | 3–7 days (limited reference laboratory availability in the region) |
| Physician Interpretation Support | Included – telephonic guidance with a licensed GP post-result | Not routinely provided by most molecular laboratories |
Physician Insight & Safety Protocols
“A positive Babesia IgG antibody titre in the absence of detectable IgM, without recent travel to an endemic region or compatible clinical features, most frequently reflects remote past exposure rather than active parasitaemia. Clinicians must correlate serology with Giemsa-stained blood smear microscopy and consider molecular PCR testing when acute babesiosis is suspected. I stress that serological findings alone should never define therapeutic decisions—comprehensive clinical integration remains essential.”
— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
Important Clinical Advisory
Do not discontinue, modify, or initiate any prescribed medication or treatment regimen without prior consultation with your treating physician. This serology test is an adjunctive diagnostic tool and does not replace clinical judgment.
Safety Exclusion Criteria & Emergency Red Flags
- Do not proceed with venipuncture if you have a known severe allergic reaction to latex or any antiseptic solution used during standard phlebotomy.
- This test is contraindicated as a first-line screening tool in asymptomatic individuals without documented epidemiological risk factors. Physician referral is required prior to testing.
- Seek emergency medical attention immediately if you experience high fever, dark-coloured urine, severe fatigue, or acute confusion after sample collection—these may indicate haemolytic crisis unrelated to the venipuncture procedure but clinically urgent.
Patient FAQ & Clinical Guidance
1. What does a positive Babesia IgG with a negative IgM result indicate?
A positive IgG antibody in the absence of IgM typically signifies past exposure to Babesia microti rather than active acute infection. This serological pattern must be interpreted alongside clinical symptoms, travel and exposure history, and confirmatory blood smear or PCR testing before any treatment decision is made.
2. Why does this test require sample submission by the 7th of the month and take 14–21 days for results?
Babesia IFA is a highly specialised serological reference assay performed in scheduled batch cycles to maintain cost efficiency and rigorous quality control using validated CDC protocols. This batched processing model ensures consistent analytical accuracy and traceability throughout the testing workflow.
3. Is fasting required before sample collection, and can my regular medications interfere with the test?
No fasting is required for this serological assay. Patients must complete the mandatory Send Out Consent Form (Form 35) prior to venipuncture. Common prescription medications do not significantly affect Babesia antibody titres; however, please inform the phlebotomist if you are taking anticoagulant therapy for appropriate post-procedure care.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Health Information Governance: This testing service complies fully with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent, data handling, and clinical safety protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Quality Certification: All laboratory procedures are performed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) at DNA Labs UAE, DHA-licensed facility number 1143.
Home Collection & Insurance Support: VIP Mobile Phlebotomy available daily from 8 AM to 11 PM. For booking or insurance verification, contact us via WhatsApp: +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | Babesia microti Antibodies (IgG & IgM) |
| Price (AED) | 1,500 |
| Turnaround Time | 14–21 Days (Batch Processing – sample required by 7th of the month) |
| Sample Type / Matrix | Serum or Plasma (Standard Venipuncture) |
| Methodology Used | Immunofluorescence Assay (IFA) – CDC Reference Standard |
| ICD-10-CM Code | B60.0, Z11.6, Z86.19 |
| LOINC Code | 94692-8 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians